期刊文献+

我院1例川崎病患儿使用阿司匹林的用药咨询并文献复习 被引量:6

Medication Consultation on Application of Aspirin in Children with Kawasaki Disease and Literature Review
下载PDF
导出
摘要 目的:探讨川崎病(KD)治疗中阿司匹林的合理用法,为提高临床药师用药咨询专业水平提供参考。方法:结合最新临床证据,为KD患儿使用阿司匹林提供相关用药咨询服务,主要包括阿司匹林的使用剂量、疗程、不良反应以及药物的剂型选择。结果:KD治疗方案主要是急性期中高剂量阿司匹林联合静脉注射大剂量丙种球蛋白,之后以小剂量阿司匹林维持,这是目前国内国际推荐的治疗原则,且阿司匹林治疗的总体安全性较好。对于儿童用药,在选择阿司匹林剂型时,采用泡腾片溶解形成液体,比肠溶制剂更适合。结论:专业的用药咨询可使患者、药师、医师三方获益。 Objective: To probe into the application of aspirin in children with Kawasaki disease (KD), so as to provide reference for improvement of professional level of medication consultation. Methods: Combined with the latest clinical evidence, medication consultation service including the dosage, course, adverse drug reactions and dosage form selection was provided for children with KD. Results: Initial therapy in KD mainly concentrated in high-dose intravenous immune globulin and moderate-dose to high-dose aspirin, and then switched to a low-dose aspirin for maintainance, which was the current domestic and international recommended treatment principle. And the overall safety of aspirin treatment was better for children' s medications, the use of effervescent tablets in form liquids was more suitable than enteric preparations when selecting aspirin dosage forms. Conclusion: Professional medication consultation can benefit patients, pharmacists and doctors.
作者 胡利华 王晓玲 Hu Lihua;Wang Xiaoling(Beijing Children's Hospital, Capital Medical University, Beijing 100045, China)
出处 《儿科药学杂志》 CAS 2018年第6期33-35,共3页 Journal of Pediatric Pharmacy
基金 国家卫计委药政司购买服务项目"保障儿童用药理论政策及基础数据研究" 药政[2017]3号
关键词 川崎病 阿司匹林 用药咨询 Kawasaki disease aspirin medication consultation
  • 相关文献

参考文献5

二级参考文献64

  • 1张清友,杜军保.不完全川崎病的诊治现状[J].中华儿科杂志,2006,44(5):339-341. 被引量:149
  • 2马娟,元刚,陈旻湖.非甾体类消炎药对胃黏膜的损伤及替普瑞酮预防作用的实验研究[J].中华医学杂志,2006,86(40):2868-2873. 被引量:12
  • 3吕树铮,宋现涛,陈韵岱,陈欣,中国经皮冠状动脉介入治疗登记调查研究协作组.中国大陆2005年度经皮冠状动脉介入治疗登记调查研究结果初步分析[J].中华心血管病杂志,2006,34(11):966-970. 被引量:43
  • 4栾好波.非甾体类抗炎药物对胃肠道损伤机制及预防[J].齐鲁药事,2007,26(5):297-299. 被引量:8
  • 5陈维忠.家长对儿童处方药物用法理解程度调查[J].全科医生,1999,8(3):144-144.
  • 6Serebruany VL,Steinhubi SR,Berger PB,et al.Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.Am J Cardio1,2005,95:1218-1222.
  • 7Walker J,Robinson J,Stewart J,et al.Does enteric-ccated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin? Interact Cardiovasc Thorac Stag,2007,6:519-522.
  • 8Kelly JP,Kanfman DW,Jurgelon JM,et al.Risk of aspirinassociated major upper-gastrointestinal bleeding with enteric-coated or buffered product.Lancet,1996,348:1413-1416.
  • 9Hemandez-Diaz S,Garcia Rodriguez LA.Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications.BMC Med,2006,4:22.
  • 10Taha AS,Angerson WJ,Prnsad R,et al.Clinical trial:the incidence and early mortality after peptic ulcer perforation,and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.Aliment Pharmacol Ther,2008,28:878-885.

共引文献311

同被引文献52

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部